— Know what they know.
Not Investment Advice
Also trades as: IVX.AX (ASX) · $vol 0M

IVIXF OTC

Invion Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -88.3% 5Y: -96.4%
$0.04
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 39 · $4.0M mcap · 66M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$6M -9.5% ▼
5Y CAGR: +5.9%
Total Liabilities
$2M +141.7% ▲
5Y CAGR: +25.2%
Shareholders Equity
$4M -32.2% ▼
5Y CAGR: +0.5%
Cash & Investments
$410K -26.8% ▼
5Y CAGR: -12.0%
Total Debt
$1M +0.0% ▲
Net Debt
$661K +218.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$6M$3M$784K$560K$410K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$6M$3M$784K$560K$410K
Net Receivables$97K$1M$1M$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$87K$55K$73K
Total Current Assets$6M$4M$2M$614K$482K
Property, Plant & Equip.$331$39K$39K$14K$4K
Goodwill & Intangibles$8M$9M$13M$6M$5M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$8M$9M$13M$6M$5M
Total Assets$14M$13M$15M$6M$6M
— Liabilities —
Accounts Payable$221K$79K$721K$357K$464K
Short-Term Debt$0$0$0$0$1M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$139K$167K$87K$270$272K
Total Current Liabilities$319K$433K$1M$815K$2M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$319K$433K$1M$815K$2M
— Equity —
Common Stock$101M$98M$148M$100M$106M
Retained Earnings-$90M-$87M-$136M-$95M-$103M
Accumulated OCI$3M$1M$2M$1M$1M
Total Stockholders Equity$14M$12M$14M$5M$4M
Total Liabilities & Equity$14M$13M$15M$6M$6M
— Key Metrics —
Total Debt$0$0$0$0$1M
Net Debt-$6M-$3M-$784K-$560K$661K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms